Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models.
about
New Therapeutic Concept of NAD Redox Balance for Cisplatin NephrotoxicityMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesNeuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.Activation of SIRT3 by the NAD⁺ precursor nicotinamide riboside protects from noise-induced hearing lossAxonal degeneration as a self-destructive defense mechanism against neurotropic virus infectionAddition of exogenous NAD+ prevents mefloquine-induced neuroaxonal and hair cell degeneration through reduction of caspase-3-mediated apoptosis in cochlear organotypic culturesNicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from PellagraAxon degeneration: Molecular mechanisms of a self-destruction pathwayModels of autoimmune demyelination in the central nervous system: on the way to translational medicine.NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents.Overexpression of Wld(S) or Nmnat2 in mauthner cells by single-cell electroporation delays axon degeneration in live zebrafish.Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery.Wallerian degeneration, wld(s), and nmnat.NAD+ protects against EAE by regulating CD4+ T-cell differentiationDiapause formation and downregulation of insulin-like signaling via DAF-16/FOXO delays axonal degeneration and neuronal loss.Ototoxic Model of Oxaliplatin and Protection from Nicotinamide Adenine DinucleotideC/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice.Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotideElevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegenerationThe Cell Death Pathway Regulates Synapse Elimination through Cleavage of Gelsolin in Caenorhabditis elegans NeuronsChemical genetic-mediated spatial regulation of protein expression in neurons reveals an axonal function for wld(s).WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.Evaluation of corticospinal axon loss by fluorescent dye tracing in mice with experimental autoimmune encephalomyelitisTriple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in DrosophilaRescuing axons from degeneration does not affect retinal ganglion cell death.Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.The importance of NAD in multiple sclerosisEvaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesisThe purine nucleosides adenosine and guanosine delay axonal degeneration in vitroMaintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.Sodium and potassium currents influence Wallerian degeneration of injured Drosophila axons.The vitamin nicotinamide: translating nutrition into clinical care.NAD and axon degeneration: from the Wlds gene to neurochemistry.NAD(+) Metabolism in Age-Related Hearing LossHDAC inhibitors and neurodegeneration: at the edge between protection and damage.Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.Wld(S), Nmnats and axon degeneration--progress in the past two decades.Axonal degeneration as a therapeutic target in the CNS.
P2860
Q26765483-532C2B7B-39B0-467F-8DC5-E528800BC094Q27023735-22726E06-B393-4713-8F42-6A60917A5983Q27303843-8E0FEE61-F639-4E4D-92DA-176F5E6B256DQ27318173-3D0948C1-A122-4011-8F7C-6F96CAC2F8DDQ27487496-E287AE85-6EAA-404A-A249-063004589EE3Q28534856-89A81551-D6C5-49D1-8BDA-F2D07B2AECAAQ28730781-19D89CC1-8FBC-4FDF-8130-9E26C2090FC9Q29013985-EEFADED9-87B0-4D4D-90ED-C1C68E95D0C3Q30483471-561E1773-EF62-445F-BCC4-96D92A1D45CEQ30581187-5D3697F8-458D-4024-97AC-DED008B53F1AQ33698363-7AFA0B8E-0FA6-4024-AB37-73A77096ACE4Q34003813-522BCBD9-4EF9-4A21-AE01-F32CA67B66E3Q34106847-049ECD39-64F7-4C0E-B755-8837AE682783Q34385222-249DE068-91FC-4C87-B3D6-D5898F8FBC16Q34539839-2A330E82-9C60-41CE-9132-241353D9C5B5Q34556923-5B5148AB-067F-47CC-A0FD-0B0FC90AFAFDQ34660816-E8CCD573-2FCD-4391-899F-5EB4DF746F73Q35182446-91C5B312-BF0B-42C2-A833-0BDE4E843D39Q35757231-5F18C57D-2FC1-49EA-9CCE-3810B34B7F5BQ35782942-7C5EE859-9075-420A-B121-7ECA37BD2221Q35799245-E862D589-5B54-4AD9-B9F5-9EF0AA8691B1Q35878214-F9FCD67D-9B81-4250-9E04-A1B502951A6BQ36492135-4FDFDEF3-AE8D-484B-B015-BC5C6CA31F9EQ36727444-F7C70BEC-BC1A-41A4-B6EA-94713D6216A3Q36749025-5EF50C2D-EC4E-475B-BD75-95D86D9C4736Q36761273-FEB5CF5D-822F-4DB2-9A89-DBA1530F7D3AQ37080194-19BC8871-129E-4C60-9E51-D6D1DB98AE31Q37118012-53CF4C9A-81DA-431B-B86E-FD3C45E0C492Q37130888-F52C91B1-55E4-43CE-9B40-8660CD16C758Q37193985-AAE479E7-4282-4E1A-9E75-1AE565547A43Q37207639-20E61ABE-CD9D-4B08-985B-470F3DCA9189Q37315208-0557ABA2-45D2-4CDE-B381-92B0F50A5624Q37345123-CCE99624-04DA-43FD-8A31-2AD719490D97Q37374047-298429C7-F7E8-4E49-82C6-0F1FEBC74AFEQ37446707-5A37F27E-F1FF-4494-A1AE-8D8277FF6F3EQ37665360-1BA23831-E236-4C99-B88B-13DCE5285709Q37685428-1AF35E94-88E9-400C-9F8F-AD03061B58B0Q37708381-46B94D86-834A-4A71-80EE-FD7E0F17DF7FQ37825829-D08CCC91-294A-48FC-84E2-99D20794F1E9Q37990880-F48EF324-4C07-452F-9378-F29ADEACE6E3
P2860
Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Protecting axonal degeneration ...... mune encephalomyelitis models.
@ast
Protecting axonal degeneration ...... mune encephalomyelitis models.
@en
type
label
Protecting axonal degeneration ...... mune encephalomyelitis models.
@ast
Protecting axonal degeneration ...... mune encephalomyelitis models.
@en
prefLabel
Protecting axonal degeneration ...... mune encephalomyelitis models.
@ast
Protecting axonal degeneration ...... mune encephalomyelitis models.
@en
P2093
P1476
Protecting axonal degeneration ...... mmune encephalomyelitis models
@en
P2093
Joanna M Hurrell
Marie Kaneko
Shinjiro Kaneko
Tanuja Chitnis
Zhigang He
P304
P356
10.1523/JNEUROSCI.2116-06.2006
P407
P577
2006-09-01T00:00:00Z